Curanex Pharmaceuticals Inc Common Stock
Market Cap
9.7M
Short interest (May 15)
0.1%
Net Short (Jun 03 ): 0.0%
Borrow Fee
47.87%
↓ 7.1%
Available Shares
300K
↑ 7.1%
Price Chart
Company Overview
Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout. Phyto-N, is a proprietary botanical extract with chemical components and pharmacological activities that harnesses potential anti-inflammatory properties of a medicinal plant.
Company Info
Market Data
Short Interest
Recent Changes
Quick Actions
Investment Risk
This is not financial advice. All investments carry risk. Do your own research before making investment decisions.